Two Mass. Pharmas See Positive Results, Others See Losses
Several Massachusetts pharmaceutical companies announced first quarter financial results, including increases in revenue from Repligen and Zalicus, and net losses from ArQule and Synta Pharmaceuticals.
300 N. Washington St., Suite 200, Falls Church, VA 22046, USA.
Phone (703) 538-7600 - Fax (703) 538-7676 - Toll free (888) 838-5578.
Copyright by FDAnews. All rights reserved. Do not duplicate or redistribute in any form.